With facilities in South San Francisco, CA and San Antonio, TX, Gryphon Bio is a provider for therapeutics solutions for neurological or neurodegenerative diseases. Traumatic brain injury (TBI), multiple sclerosis (MS) and epilepsy are major causes of death and disability. Gryphon Bio was initiated as the means whereby to harness discovery by the firm's founders of unexpected waves of proteins observed in the blood of animals and patients. Mission: to develop and market the first precision medicine to accelerate brain repair and improve cognition. Vision: To pioneer temporal diagnostics (tDx)driven precision medicines to improve the lives of patients with neurological or neurodegenerative disease
